2023 COPD Guidelines Update

Antonio Anzueto

COPD Exacerbations: if Not, What Else?

Temple Lung Center

J. Bon

COPD Classification and Practical Management Strategies

PulmPEEPs

D. Furfaro, K. Montemayor, R. A Wise, W. Labaki

COVID-19 & ICU FAQ Answered: When Should We Intubate & How Do We Adj…

Hassan Bencheqroun MD FCCP

ECG Interpretation: Everything You Need to Know to Understand and In…

Houston Methodist DeBakey Heart and Vascular Center

A. Dave

Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, …

National Jewish Health

J. P. Woodrow

GOLD 2023 Update: Implications for Clinical Practice

Jill Ohar

CHEST 2021: Patient With Intermediate Risk-PE Should Go for Thrombol…

CHEST 2021 Coverage

B. Dalal

Inhaler Selection in COPD

CHEST 2022 Coverage

D. Mahler

Nontuberculous Mycobacterial Lung Disease: Epidemiology and Overview

National Jewish Health

S. Kasperbauer, D. Griffith

ATS 2022: Before We Can Run - Racial Health Disparities in Lung Dise…

Aaron Baugh

COPD: Dual Vs. Triple Therapy

Stephen Brunton

Management of Chronic Respiratory Failure With Non-Invasive Ventilat…

Michigan Medicine

P. Choi

COPD: Current and Emerging Management Strategies

Brigham and Women's Hospital

C. P. Hersh

LAMA, LABA, ICS, PDE4i, Triple, Dual, Double: Unraveling the Pharmac…

Temple Lung Center

M. Dransfield

Therapeutic Options for Acute COPD Exacerbations: GOLD 2024 Guidelin…

Sami Hossri

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

ATS 2024 Insights: Effectiveness of BLVR in COPD Patients With AAT D…

Insights from 2024 ATS Annual Meeting

M. Nicholson

COPD 2024 and Beyond: Emerging Treatments

National Jewish Health

S. Lommatzsch

Paradigm Shifts in Chronic Respiratory Failure

Michigan Medicine

P. Choi